source
- Biotech executives pocket nearly $1 billion in M&A golden parachutes, 12 receive $35M+ payoutsAn Endpoints News analysis identified a group of twelve biotech leaders who collectively earned close to $1 billion in exit compensation after selling their companies. Each of these executives sec…
- Ethyreal Bio secures $101M to develop treatments for Graves' disease and thyroid eye diseaseEthyreal Bio, a newly unveiled biotech, announced it has raised $101 million in financing. The round was led by venture firms Atlas Venture and Medicxi. The capital will be used to advance therape…